"Efesovir" (FS-1) for COVID-19, Phase 2
Clinical trial NCT05060705 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05060705
- Sponsor
- Scientific Center for Anti-infectious Drugs, Kazakhstan
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-01
- Primary completion
- 2026-04-01
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.